ECONOMIC EVALUATION OF INFLIXIMAB AND ADALIMUMAB FOR CROHN'S DISEASE

被引：0
|
作者：
Hughes, D. A. [1 ]
Kikuchi, T. [1 ]
Bodger, K. [2 ]
机构：
[1] Bangor Univ, Bangor, Gwynedd, Wales
[2] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73358-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [1] Commentary: infliximab or adalimumab in Crohn's disease?
    Sprakes, M. B.
    Hamlin, P. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (04) : 398 - 398
  • [2] Infliximab vs Adalimumab for Crohn's Disease
    Dhillon, Angad S.
    Harris, Adam W.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (01) : 210 - 210
  • [3] Infliximab vs. Adalimumab for Crohn's disease
    Mulani, P.
    Chao, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (10) : 1265 - 1266
  • [4] Comparative Effectiveness of Infliximab and Adalimumab for Crohn's Disease
    Haynes, Kevin
    Osterman, Mark T.
    Delzell, Elizabeth
    Zhang, Jie
    Bewtra, Meenakshi
    Brensinger, Colleen
    Chen, Lang
    Xie, Fenlong
    Curtis, Jeffrey R.
    Lewis, James D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 359 - 359
  • [5] Comparative Effectiveness of Infliximab and Adalimumab for Crohn's Disease
    Osterman, Mark T.
    Haynes, Kevin
    Delzell, Elizabeth
    Zhang, Jie
    Bewtra, Meenakshi
    Brensinger, Colleen
    Chen, Lang
    Xie, Fenlong
    Curtis, Jeffrey R.
    Lewis, James D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (05) : 811 - U137
  • [6] CERTOLIZUMAB PEGOL IN CROHN'S DISEASE REFRACTORY TO INFLIXIMAB AND ADALIMUMAB
    Jose, Morales Lara Ma
    Penella Monica, Martinez
    Guzman Diana, Lacruz
    Vidal Vanessa, Jorge
    Maneiro Vicente, Santaclara
    Sanchez Senador, Moran
    del Carmen, Mira Sirvent Ma
    ATENCION FARMACEUTICA, 2009, 11 (03): : 178 - 180
  • [7] INFLIXIMAB VERSUS ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE
    Maas, Laura A.
    Limketkai, Berkeley N.
    Lazarev, Mark
    Melia, Joanna
    Selaru, Florin M.
    Parian, Alyssa M.
    GASTROENTEROLOGY, 2022, 162 (07) : S817 - S817
  • [8] Effectiveness of infliximab after adalimumab failure in Crohn's disease
    María Chaparro
    Montserrat Andreu
    Manuel Barreiro-de Acosta
    Esther García-Planella
    Elena Ricart
    Eugeni Domènech
    María Esteve
    Olga Merino
    Pilar Nos
    Mireia Pealva
    Javier P Gisbert
    World Journal of Gastroenterology, 2012, (37) : 5219 - 5224
  • [9] Effectiveness of Infliximab After Adalimumab Failure in Crohn's Disease
    Chaparro, Maria
    Andreu, Montserrat
    Barreiro, Manuel
    Garcia-Planella, Esther
    Ricart, Elena
    Domenech, Eugeni
    Esteve, Maria
    Merino, Olga
    Nos, Pilar
    Penalva, Mireia
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2010, 138 (05) : S694 - S694
  • [10] Effectiveness of infliximab after adalimumab failure in Crohn's disease
    Chaparro, Maria
    Andreu, Montserrat
    Barreiro-de Acosta, Manuel
    Garcia-Planella, Esther
    Ricart, Elena
    Domenech, Eugeni
    Esteve, Maria
    Merino, Olga
    Nos, Pilar
    Penalva, Mireia
    Gisbert, Javier P.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (37) : 5219 - 5224
12345